Index by author
Agrawal, Ankit
- You have accessWhen should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?Osamah Z. Badwan, MD, Lorenzo Braghieri, MD, Warren Skoza, MD, Ankit Agrawal, MD, Venu Menon, MD and W. H. Wilson Tang, MDCleveland Clinic Journal of Medicine January 2024, 91 (1) 47-51; DOI: https://doi.org/10.3949/ccjm.91a.23034
Evidence from clinical trials supports starting these medications as early as possible in patients hospitalized with acute decompensated heart failure who do not have clear contraindications to them.
Alexander, Jason T.
- You have access2023 Update in ambulatory general internal medicineJason T. Alexander, MD, Simran K. Singh, MD, Sachin D. Shah, MD, Brianna Lambert, MD and Jeremy P. Smith, MDCleveland Clinic Journal of Medicine January 2024, 91 (1) 40-46; DOI: https://doi.org/10.3949/ccjm.91a.23056
Topics reviewed include prevention of chronic kidney disease progression, diet for preventing secondary cardiovascular disease, prevention of kidney-stone recurrence, drug therapy for weight loss, and cholesterol management.
Alomari, Mohammad
- You have accessGastric intestinal metaplasia and gastric cancer prevention: Watchful waitingShrouq Khazaaleh, MD, Mohammad Alomari, MD, Mamoon Ur Rashid, MD, Daniel Castaneda, MD and Fernando J. Castro, MDCleveland Clinic Journal of Medicine January 2024, 91 (1) 33-39; DOI: https://doi.org/10.3949/ccjm.91a.23015
Malignancy develops in only a small minority of patients with gastric intestinal metaplasia. Recognition of clinical, endoscopic, and histologic features linked with cancer development is critical to identifying patients who require endoscopic surveillance.
Badwan, Osamah Z.
- You have accessWhen should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?Osamah Z. Badwan, MD, Lorenzo Braghieri, MD, Warren Skoza, MD, Ankit Agrawal, MD, Venu Menon, MD and W. H. Wilson Tang, MDCleveland Clinic Journal of Medicine January 2024, 91 (1) 47-51; DOI: https://doi.org/10.3949/ccjm.91a.23034
Evidence from clinical trials supports starting these medications as early as possible in patients hospitalized with acute decompensated heart failure who do not have clear contraindications to them.
Batur, Pelin
- You have accessLate complications after allogeneic hematopoietic cell transplantPelin Batur, MD, FACP, MSCPCleveland Clinic Journal of Medicine January 2024, 91 (1) 19; DOI: https://doi.org/10.3949/ccjm.91c.01001
Braghieri, Lorenzo
- You have accessWhen should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?Osamah Z. Badwan, MD, Lorenzo Braghieri, MD, Warren Skoza, MD, Ankit Agrawal, MD, Venu Menon, MD and W. H. Wilson Tang, MDCleveland Clinic Journal of Medicine January 2024, 91 (1) 47-51; DOI: https://doi.org/10.3949/ccjm.91a.23034
Evidence from clinical trials supports starting these medications as early as possible in patients hospitalized with acute decompensated heart failure who do not have clear contraindications to them.
Buda, Kevin G.
- You have accessConsumer-grade wearable cardiac monitors: What they do well, and what needs workAbdilahi Mohamoud, MBBS, Joseph Jensen, MD and Kevin G. Buda, DOCleveland Clinic Journal of Medicine January 2024, 91 (1) 23-29; DOI: https://doi.org/10.3949/ccjm.91a.23030
The authors review common consumer-grade wearables, including the accuracy of these monitors compared with medical-grade devices, and present an approach to managing rate or rhythm abnormalities identified on at-home monitoring.
Castaneda, Daniel
- You have accessGastric intestinal metaplasia and gastric cancer prevention: Watchful waitingShrouq Khazaaleh, MD, Mohammad Alomari, MD, Mamoon Ur Rashid, MD, Daniel Castaneda, MD and Fernando J. Castro, MDCleveland Clinic Journal of Medicine January 2024, 91 (1) 33-39; DOI: https://doi.org/10.3949/ccjm.91a.23015
Malignancy develops in only a small minority of patients with gastric intestinal metaplasia. Recognition of clinical, endoscopic, and histologic features linked with cancer development is critical to identifying patients who require endoscopic surveillance.
Castro, Fernando J.
- You have accessGastric intestinal metaplasia and gastric cancer prevention: Watchful waitingShrouq Khazaaleh, MD, Mohammad Alomari, MD, Mamoon Ur Rashid, MD, Daniel Castaneda, MD and Fernando J. Castro, MDCleveland Clinic Journal of Medicine January 2024, 91 (1) 33-39; DOI: https://doi.org/10.3949/ccjm.91a.23015
Malignancy develops in only a small minority of patients with gastric intestinal metaplasia. Recognition of clinical, endoscopic, and histologic features linked with cancer development is critical to identifying patients who require endoscopic surveillance.
Cho, Leslie S.
- You have accessNonstatin therapy to reduce low-density lipoprotein cholesterol and improve cardiovascular outcomesAbhayjit Singh, MD and Leslie S. Cho, MDCleveland Clinic Journal of Medicine January 2024, 91 (1) 53-63; DOI: https://doi.org/10.3949/ccjm.91a.23058
Several new nonstatin medications have been approved in recent years, with robust data from clinical trials supporting their use in atherosclerotic disease.